(RxWiki News) The US Food and Drug Administration (FDA) has approved the first generic version of Truvada.
Truvada is a combination of two medications: emtricitabine and tenofovir disoproxil fumarate tablets. This medication is approved to treat patients with human immunodeficiency virus (HIV-1) and is given in combination with other medications for HIV. It’s also approved for pre-exposure prophylaxis (PrEP) to prevent sexually acquired HIV infection in adults who are at high risk.
The FDA approved the generic version of emtricitabine and tenofovir disoproxil fumarate tablets after it was found to be bioequivalent and therapeutically equivalent to the brand-name Truvada.
This medication is available in tablet form and is to be taken by mouth once daily.
The generic version of Truvada does not cure HIV or acquired immune deficiency syndrome (AIDS). Instead, this medication helps manage HIV-1 infection and reduce HIV-1-related illnesses. Patients must take their medication as prescribed for it to work.
It is also important to practice safe sex and use condoms to reduce the chance of contact with body fluids during sex.
The generic version of Truvada is a product of Teva Pharmaceuticals USA.